Cytomegalovirus Immune reconstitution in cord blood transplant recipients on letermovir prophylaxis.
Christin Rogers MarksKyle C MolinaKrystle GarthJonathan A GutmanAdriana WeinbergPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2023)
Approximately 50% of CBT recipients reconstituted CMV-CMI during letermovir prophylactic therapy. However, CMV-CMI did not reach levels protective against CsCMV. Extension of CMV prophylaxis beyond Day+90 may be considered in CMV-seropositive CBT recipients.